Commentary
Business & Economics
Read about latest tax hike push at State Capitol
California’s Already High Taxes Could Increase if Democratic Legislators Prevail
California has been losing businesses and residents to states with lower tax burdens for years, and the response in Sacramento has been puzzling. Rather than trying to compete with those states, the counter has been to instead raise taxes even higher. Following this formula, legislators recently passed Assembly Constitutional Amendment
Commentary
Read about lack of action on state water infrastructure
Farmers Flush With Water Now, But State Still Hasn’t Prepared for the Next Drought
For most of the state, the drought is over. The Central Valley is receiving their full state water supply allocation and farmers don’t need to pull water from the ground to keep their crops from dying of thirst. But that doesn’t mean the signs along Interstate 5 and Highway 99
Commentary
Learn how price controls threaten access to drugs
Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.
President Joe Biden celebrated a milestone today—but American patients have no reason to cheer. The White House announced the first 10 prescription drugs that, starting in 2026, will be subject to price controls authorized by the Inflation Reduction Act . . . It’s laudable that lawmakers want to reduce out-of-pocket
Commentary
Learn About GOP Healthcare Reform Plans
Republican candidates have sensible ideas for Medicare reform
Though they didn’t mention them onstage, several GOP candidates have previously proposed ideas for Medicare reform. That’s a good thing. The program’s Part A hospital insurance trust fund is set to run out of money in 2031. Absent major changes, the program will only continue hurtling toward insolvency. The problem
Commentary
Read latest on government price controls
Medicaid Drug Price Transparency Rule Is More Sinister Than It Seems
The Biden administration claims to support price transparency in healthcare. The Centers for Medicare and Medicaid Services has formally warned hundreds of hospitals to comply with federal rules requiring them to post their prices publicly. And the agency just rolled out a new rule designed to “advance prescription drug transparency
Commentary
Read latest on single-payer healthcare
Left’s Rhetoric Unmoored from Reality: U.S. Likes Its Healthcare
Three in four rate their health plan as either good or very good. And satisfaction ratings barely differed across political, racial, or socioeconomic groups. America’s health insurance system isn’t perfect. But, as these numbers suggest, it works pretty well for most people — which is more than can be said for
Commentary
Read the latest about PBMs
It’s Time To End the PBM Shakedown
Who says bipartisanship is dead? In the House and Senate, members of both parties are advancing legislation to check the power of pharmacy benefit managers (PBMs), the self-dealing middlemen in the drug supply chain that inflate Americans’ spending on prescriptions by billions of dollars a year. By shining a light
Commentary
Another reason why single-payer would be bad for US
Britain Offers a Cautionary Tale for ‘Medicare for All’
King Charles III’s coronation wasn’t the only historic event Great Britain marked this year. The country’s revered National Health Service is celebrating this summer the 75th anniversary of its founding. It’s a birthday Americans should take note of. The NHS has been an inspiration to generations of American leftists, who
Commentary
Read latest about affirmative action
Ending medical-school affirmative action will be a plus for patients
The US Supreme Court effectively prohibited university admissions officers from giving preferential treatment to applicants based on their race this summer. Many medical-school leaders decried the high court’s ruling, claiming the ban will lead to less diversity within their student bodies, a less diverse crop of physicians and worse outcomes
Commentary
Cancer Patients Need Private Innovation, Not Gov’t Meddling
President Joe Biden just announced a new effort that he hopes will spur the development of better, more precise cancer surgery technologies. The program is part of his administration’s “Cancer Moonshot,” which aims to halve cancer death rates in the United States by 2047. Ironically, one of the biggest obstacles to achieving
Read about latest tax hike push at State Capitol
California’s Already High Taxes Could Increase if Democratic Legislators Prevail
California has been losing businesses and residents to states with lower tax burdens for years, and the response in Sacramento has been puzzling. Rather than trying to compete with those states, the counter has been to instead raise taxes even higher. Following this formula, legislators recently passed Assembly Constitutional Amendment
Read about lack of action on state water infrastructure
Farmers Flush With Water Now, But State Still Hasn’t Prepared for the Next Drought
For most of the state, the drought is over. The Central Valley is receiving their full state water supply allocation and farmers don’t need to pull water from the ground to keep their crops from dying of thirst. But that doesn’t mean the signs along Interstate 5 and Highway 99
Learn how price controls threaten access to drugs
Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.
President Joe Biden celebrated a milestone today—but American patients have no reason to cheer. The White House announced the first 10 prescription drugs that, starting in 2026, will be subject to price controls authorized by the Inflation Reduction Act . . . It’s laudable that lawmakers want to reduce out-of-pocket
Learn About GOP Healthcare Reform Plans
Republican candidates have sensible ideas for Medicare reform
Though they didn’t mention them onstage, several GOP candidates have previously proposed ideas for Medicare reform. That’s a good thing. The program’s Part A hospital insurance trust fund is set to run out of money in 2031. Absent major changes, the program will only continue hurtling toward insolvency. The problem
Read latest on government price controls
Medicaid Drug Price Transparency Rule Is More Sinister Than It Seems
The Biden administration claims to support price transparency in healthcare. The Centers for Medicare and Medicaid Services has formally warned hundreds of hospitals to comply with federal rules requiring them to post their prices publicly. And the agency just rolled out a new rule designed to “advance prescription drug transparency
Read latest on single-payer healthcare
Left’s Rhetoric Unmoored from Reality: U.S. Likes Its Healthcare
Three in four rate their health plan as either good or very good. And satisfaction ratings barely differed across political, racial, or socioeconomic groups. America’s health insurance system isn’t perfect. But, as these numbers suggest, it works pretty well for most people — which is more than can be said for
Read the latest about PBMs
It’s Time To End the PBM Shakedown
Who says bipartisanship is dead? In the House and Senate, members of both parties are advancing legislation to check the power of pharmacy benefit managers (PBMs), the self-dealing middlemen in the drug supply chain that inflate Americans’ spending on prescriptions by billions of dollars a year. By shining a light
Another reason why single-payer would be bad for US
Britain Offers a Cautionary Tale for ‘Medicare for All’
King Charles III’s coronation wasn’t the only historic event Great Britain marked this year. The country’s revered National Health Service is celebrating this summer the 75th anniversary of its founding. It’s a birthday Americans should take note of. The NHS has been an inspiration to generations of American leftists, who
Read latest about affirmative action
Ending medical-school affirmative action will be a plus for patients
The US Supreme Court effectively prohibited university admissions officers from giving preferential treatment to applicants based on their race this summer. Many medical-school leaders decried the high court’s ruling, claiming the ban will lead to less diversity within their student bodies, a less diverse crop of physicians and worse outcomes
Cancer Patients Need Private Innovation, Not Gov’t Meddling
President Joe Biden just announced a new effort that he hopes will spur the development of better, more precise cancer surgery technologies. The program is part of his administration’s “Cancer Moonshot,” which aims to halve cancer death rates in the United States by 2047. Ironically, one of the biggest obstacles to achieving
